Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)

Summary

This is a multicenter, open-label, randomized, parallel group comparison study to verify the clinical equivalency of the old formulation (50 mcg as mometasone furoate \[MF\] in 50 μL of solution per spray) to the new formulation (50 mcg as MF in 100 μL of solution per spray) in patients with perennial allergic rhinitis.

Timeline

Start

2005-02-01

Primary completion

2005-04-01

Completion

2005-04-01

Publications

• Results T. Ishikawa et. al; Practica otologica. Suppl.123 Page1-18 (2008.12) -Japanese language journal

Drugs

Indications